Morihito Okada

11PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyLiquid biopsiesBiomedical imagingEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 27, 2026
Perioperative Durvalumab for Resectable NSCLC: Updated Outcomes for Japanese Patients in AEGEAN.

|Dec 19, 2025
IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer.

Morihito Okada, Shunichi Sugawara, Yasutaka Watanabe

|Jan 03, 2024
Effectiveness of pleurodesis for postoperative air leaks after lung resection.

Norifumi Tsubokawa, Takahiro Mimae, Risa Ito

|Oct 21, 2022
Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy.

Kanako Suzuki, Shinsuke Sasada, Hiromi Nishi

|Sep 05, 2022
Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010).

Hirotsugu Kenmotsu, Shunichi Sugawara, Yasutaka Watanabe

|Nov 04, 2020
Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer.

Yuri Kimura, Shinsuke Sasada, Akiko Emi

Pageof 2

Frequent Collaborators

5 joint publications

Shinsuke Sasada

4 joint publications

Yasuhiro Tsutani

4 joint publications

Takayuki Kadoya

3 joint publications

Norio Masumoto